Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Diagnostics (Basel, Switzerland)|August 29, 2024
Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk EstimationNikolaos Tsoulos, Eirini Papadopoulou, Konstantinos Agiannitopoulos, et al.
American Journal of Hematology|April 4, 2017
Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapyEfstathios Kastritis, Maria Gavriatopoulou, Maria Roussou, et al.
Blood Advances|December 11, 2019
Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasoneEfstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, et al.
Blood|February 2, 2018
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosisEfstathios Kastritis, Ioannis Papassotiriou, Giampaolo Merlini, et al.
JCO Precision Oncology|January 24, 2025
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 TrialSun Young Rha, Yanqiao Zhang, Anneli Elme, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 22, 2019
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosisEfstathios Kastritis, Maria Gavriatopoulou, Maria Roussou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2020
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With MyelomaEfstathios Kastritis, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, et al.
Cancers|January 11, 2024
Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic DepictionDimitrios C Ziogas, Eirini Papadopoulou, Helen Gogas, et al.
JCO Precision Oncology|January 25, 2024
Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical PracticeEirini Papadopoulou, George Rigas, Elena Fountzilas, et al.
Hemasphere|January 25, 2020
Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline TherapyEvangelos Terpos, Ioannis V Kostopoulos, Efstathios Kastritis, et al.
Pageof 9